Back

Atrial and ventricular arrhythmias with immune checkpoint inhibitor therapy in patients without evidence of myocarditis

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: T-cells, checkpoint inhibitors, and cardiac complications Cardio-Oncology ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Julius Heemelaar

Alrijne Hospital Leiderdorp, Leiderdorp (Netherlands (The))

7 More presentations in this session

Presentation thumbnail
Cardiovascular complications of chimeric antigen receptor (CAR)-T cell therapy
Associate Professor F. Guerra (Ancona, IT)
Abstract Slides Video
Presentation thumbnail
Arterial inflammation induced by immune checkpoint inhibitors assessed on 18F-FDG PET-CT scans in stage III/IV melanoma patients
Miss E. Polomski (Leiden, NL)
Abstract Slides Video
Presentation thumbnail
Immune checkpoint inhibitors and atherosclerotic cardiovascular events: a retrospective cohort study
Doctor S. Tan (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
Gender differences in cardio-oncology care of patients treated with immune checkpoint inhibitor therapy
Associate Professor R. Mincu (Essen, DE)
Abstract Slides Video
Presentation thumbnail
Anti CTLA-4 and PD-1 monoclonal antibodies increases systemic SDF-1 and galectin-3 levels and reduces myocardial strain through NLRP3 and MyD-88 pathways
Doctor N. Maurea (Naples, IT)
Abstract Slides Video

Access the full session

Session thumbnail
T-cells, checkpoint inhibitors, and cardiac complications

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources